JP2015520628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520628A5 JP2015520628A5 JP2015509510A JP2015509510A JP2015520628A5 JP 2015520628 A5 JP2015520628 A5 JP 2015520628A5 JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015509510 A JP2015509510 A JP 2015509510A JP 2015520628 A5 JP2015520628 A5 JP 2015520628A5
- Authority
- JP
- Japan
- Prior art keywords
- drug delivery
- delivery system
- implant
- lacrimal implant
- lacrimal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 claims 36
- 238000012377 drug delivery Methods 0.000 claims 32
- 239000003814 drug Substances 0.000 claims 11
- 230000004410 intraocular pressure Effects 0.000 claims 11
- GGXICVAJURFBLW-CEYXHVGTSA-N latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 claims 11
- 229960001160 latanoprost Drugs 0.000 claims 11
- 229940124597 therapeutic agent Drugs 0.000 claims 9
- 206010030043 Ocular hypertension Diseases 0.000 claims 7
- 206010030348 Open-Angle Glaucoma Diseases 0.000 claims 7
- 241000083513 Punctum Species 0.000 claims 7
- 230000037431 insertion Effects 0.000 claims 5
- 238000003780 insertion Methods 0.000 claims 5
- 238000013268 sustained release Methods 0.000 claims 5
- 239000012730 sustained-release form Substances 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 239000004944 Liquid Silicone Rubber Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 229920001296 polysiloxane Polymers 0.000 claims 2
- 229920002379 silicone rubber Polymers 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 1
- 229920001971 elastomer Polymers 0.000 claims 1
- 239000000040 green colorant Substances 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 239000004033 plastic Substances 0.000 claims 1
- 229920003023 plastic Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000005060 rubber Substances 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261642287P | 2012-05-03 | 2012-05-03 | |
| US61/642,287 | 2012-05-03 | ||
| US201261644401P | 2012-05-08 | 2012-05-08 | |
| US201261644397P | 2012-05-08 | 2012-05-08 | |
| US61/644,401 | 2012-05-08 | ||
| US61/644,397 | 2012-05-08 | ||
| US201261659921P | 2012-06-14 | 2012-06-14 | |
| US61/659,921 | 2012-06-14 | ||
| US201261680641P | 2012-08-07 | 2012-08-07 | |
| US61/680,641 | 2012-08-07 | ||
| US201261717615P | 2012-10-23 | 2012-10-23 | |
| US61/717,615 | 2012-10-23 | ||
| PCT/IB2013/000694 WO2013164671A1 (en) | 2012-05-03 | 2013-02-27 | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520628A JP2015520628A (ja) | 2015-07-23 |
| JP2015520628A5 true JP2015520628A5 (enExample) | 2016-04-14 |
| JP6213560B2 JP6213560B2 (ja) | 2017-10-18 |
Family
ID=49514247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015509510A Active JP6213560B2 (ja) | 2012-05-03 | 2013-02-27 | 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2844224B1 (enExample) |
| JP (1) | JP6213560B2 (enExample) |
| CN (1) | CN105473130A (enExample) |
| CA (1) | CA2872338C (enExample) |
| HK (1) | HK1222810A1 (enExample) |
| IN (1) | IN2014DN09713A (enExample) |
| WO (1) | WO2013164671A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG187770A1 (en) | 2010-08-12 | 2013-03-28 | Univ Nanyang Tech | A liposomal formulation for ocular drug delivery |
| US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
| GB201714392D0 (en) * | 2017-09-07 | 2017-10-25 | Marsteller Laurence | Methods and devices for treating glaucoma |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3321108A (en) | 1965-11-26 | 1967-05-23 | William E Bowe | Printing ink dispenser |
| US3681608A (en) | 1971-03-17 | 1972-08-01 | Us Navy | Laser beam receiver having a high signal to noise ratio |
| US4281654A (en) | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
| US4952581A (en) | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
| US4936008A (en) | 1988-05-09 | 1990-06-26 | Teledyne Mec | Laser striping method for assembling TWT |
| US4934708A (en) | 1988-05-20 | 1990-06-19 | Kolkind Gerald L | Family quiz board game |
| US5296504A (en) | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| US5259508A (en) | 1992-08-27 | 1993-11-09 | Beckerman Stephen M | Protective shipping package |
| ES2105333T3 (es) | 1992-10-13 | 1997-10-16 | Alcon Lab Inc | Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma. |
| US6622308B1 (en) | 1999-03-23 | 2003-09-16 | Scientific-Atlanta, Inc. | Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner |
| US6534693B2 (en) | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
| US7300364B2 (en) | 2004-02-06 | 2007-11-27 | Acushnet Company | Multi-layer golf ball having velocity gradient from faster center to slower cover |
| AU2004215898A1 (en) | 2003-02-26 | 2004-09-10 | Medivas, Llc | Bioactive stents and methods for use thereof |
| JP4104137B2 (ja) * | 2003-05-30 | 2008-06-18 | 有限会社エム・エル・シー | 涙点プラグ |
| US7662864B2 (en) | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| US20050129731A1 (en) | 2003-11-03 | 2005-06-16 | Roland Horres | Biocompatible, biostable coating of medical surfaces |
| KR100850133B1 (ko) | 2004-01-05 | 2008-08-04 | 니콕스 에스. 에이. | 프로스타글란딘 나이트로옥시 유도체 |
| US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
| AU2005269988B2 (en) | 2004-07-02 | 2012-02-02 | Mati Therapeutics Inc. | Treatment medium delivery device and methods for delivery |
| CA2648066C (en) | 2006-03-31 | 2012-07-03 | Forsight Labs, Llc | Drug delivery methods, structures, and compositions for nasolacrimal system |
| WO2008083118A1 (en) * | 2006-12-26 | 2008-07-10 | Qlt Plug Delivery, Inc. | Drug delivery implants for inhibition of optical defects |
| UY30883A1 (es) | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| CA2698508C (en) | 2007-09-07 | 2017-06-06 | Alan R. Rapacki | Lacrimal implants and related methods |
| RU2010112417A (ru) | 2007-09-07 | 2011-10-10 | Клт Плаг Диливери, Инк. (Us) | Обнаружение лакримальных имплантатов |
| KR20100058620A (ko) | 2007-09-07 | 2010-06-03 | 큐엘티 플러그 딜리버리, 인코포레이티드 | 눈물 임플랜트용 삽입 및 적출 기구 |
| JP5555162B2 (ja) | 2007-09-07 | 2014-07-23 | キュー エル ティー インク. | 治療薬剤の持続放出のための薬物コア |
| WO2009137085A2 (en) * | 2008-05-09 | 2009-11-12 | Qlt Plug Delivery, Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| EP2389221B1 (en) | 2009-01-23 | 2023-08-16 | Mati Therapeutics Inc. | Sustained released delivery of one or more agents |
| SG174133A1 (en) * | 2009-02-23 | 2011-10-28 | Quadra Logic Tech Inc | Lacrimal implants and related methods |
| CA2781629A1 (en) | 2009-11-27 | 2011-06-03 | Sascha K. Zarins | Lacrimal implants including split and insertable drug core |
-
2013
- 2013-02-27 CA CA2872338A patent/CA2872338C/en active Active
- 2013-02-27 JP JP2015509510A patent/JP6213560B2/ja active Active
- 2013-02-27 HK HK16111148.0A patent/HK1222810A1/zh unknown
- 2013-02-27 CN CN201380035719.2A patent/CN105473130A/zh active Pending
- 2013-02-27 EP EP13784720.8A patent/EP2844224B1/en active Active
- 2013-02-27 WO PCT/IB2013/000694 patent/WO2013164671A1/en not_active Ceased
-
2014
- 2014-11-18 IN IN9713DEN2014 patent/IN2014DN09713A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2727203T3 (es) | Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular | |
| CN102014816B (zh) | 泪管植入物及相关方法 | |
| JP5415262B2 (ja) | 活性剤送達用の涙点プラグ | |
| JP4837861B2 (ja) | ドラッグデリバリ製剤 | |
| JP6385423B2 (ja) | 治療物質送達用の眼移植片 | |
| ES2740352T3 (es) | Dispositivo ocular | |
| TW200950817A (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| US20090306608A1 (en) | Ophthalmic devices for the controlled release of active agents | |
| JP2009508587A (ja) | 眼の処置を提供するための薬剤送達装置および方法 | |
| TW201012469A (en) | Combination treatment of glaucoma | |
| US20130018360A1 (en) | Method for delivering ophthalmic drugs | |
| SI2799064T1 (en) | Biodegradable eye implant | |
| TW201201782A (en) | Punctal plugs for controlled release of therapeutic agents | |
| AU2005269599A1 (en) | Implantable device having reservoir with controlled release of medication and method of manufacturing the same | |
| WO2016031535A1 (ja) | 眼瞼内装用具 | |
| JP2015520628A5 (enExample) | ||
| CN102781452B (zh) | 减少与皮质类固醇的眼内使用相关的眼压的发生率的方法 | |
| US20220331160A1 (en) | Static pin insertion tool for lacrimal implant | |
| TW201304758A (zh) | 用於控制治療劑釋放之淚管塞 | |
| Campochiaro | Pharmacokinetics of sustained-delivery fluocinolone acetonide for DMO | |
| Yong-rong et al. | The clinical analysis of posterior capsule rapture during phacoemulsification |